The automated endoscope reprocessors (AER) market involves machines that clean and disinfect flexible endoscopes to prevent infections and meet strict hospital safety standards. These systems provide a validated, automated process that reduces human error compared to manual cleaning. Market growth is driven by the rising number of endoscopic procedures for gastrointestinal and respiratory disorders, increasing focus on infection control, and stricter healthcare regulations. Hospitals, ambulatory surgical centers, and specialty clinics are key users, with North America and Europe leading adoption, while Asia-Pacific is expected to grow fastest as healthcare infrastructure expands and awareness of patient safety increases.
The global automated endoscope reprocessors (AER) market size was valued at USD 697.7 million in 2024 and is projected to grow from USD 725.6 million in 2025 to USD 1,006.4 million by 2032, exhibiting a CAGR of 4.8% during the forecast period. North America dominated the automated endoscope reprocessors (AER) market with a 49% share in 2024, driven by stringent infection control regulations, growing endoscopic procedures, and advanced healthcare infrastructure.
Top Companies in the Market
- STERIS (U.S.)
- Getinge (Sweden)
- ASP (Fortive) (U.S.)
- Olympus Corporation (Japan)
- Steelco S.p.A. (Italy)
- ARC Healthcare Solutions Inc. (Canada)
- CHOYANG (South Korea)
- NUOVA SB SYSTEM S.R.L. (Italy)
Key Industry Development
In September 2024, Olympus Corporation announced the launch of “Sapphire,” its first flexible endoscope sterilization facility in Melbourne, Australia. The facility was designed to deliver sterilization services to clinical institutions, highlighting the company’s commitment to advancing infection prevention practices.
Market Drivers
- Rising prevalence of endoscopic procedures across gastrointestinal, urology, pulmonology, and oncology fields is increasing demand for reliable reprocessing systems.
- Growing awareness of healthcare-associated infections (HAIs) and their impact on patient outcomes is boosting adoption of automated systems over manual cleaning.
- Global aging population and associated chronic diseases are creating higher procedural volumes requiring advanced cleaning technologies.
- Expansion of healthcare infrastructure in emerging economies is creating opportunities for the installation of cost-effective and portable AER systems.
Market Restraints
- High capital investment required for acquiring and installing AER systems is a challenge for smaller healthcare facilities.
- Recurring expenses for disinfectants, maintenance, and consumables can limit adoption among budget-sensitive hospitals and clinics.
- Shortage of skilled professionals in developing nations poses operational challenges, as correct usage and maintenance of AERs require training.
Market Coverage and Scope
The Automated Endoscope Reprocessors market covers multiple aspects including product type, loading type, portability, endoscope compatibility, and end-user segments. The analysis provides a holistic view of demand patterns across hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings. It also emphasizes the regulatory landscape that enforces strict infection control practices, driving healthcare providers to shift from manual to automated solutions.
Market Segmentation
- By Type: Dual-basin AERs dominated in 2024 due to their efficiency in preventing cross-contamination. Single-basin systems are preferred in smaller facilities for their affordability and compact design.
- By Loading Type: Front-loading AERs led the segment in 2024, offering higher throughput and compatibility. Top-loading systems remain useful in niche applications.
- By Portability: Stationary units hold the majority share, while mobile units are gaining traction for their flexibility in facilities with space constraints.
- By Endoscope Type: Flexible endoscope reprocessing dominates due to the widespread use of flexible devices in diagnostics and treatments. Hybrid systems capable of reprocessing both rigid and flexible scopes are gaining momentum.
- By End-User: Hospitals and ambulatory surgical centers represent the largest end-user segment, followed by specialty clinics that are increasingly adopting AERs for outpatient procedures.
Regional Insights
North America held a dominant share of approximately 49% in 2024, valued at USD 341.9 million. Strong healthcare infrastructure, high procedural volumes, and regulatory enforcement underpin this leadership.
Europe emerged as the second-largest market, supported by stringent infection prevention regulations, rising investments in hospital hygiene, and government-led initiatives.
Asia Pacific is projected to grow at the fastest CAGR through 2032, fueled by the expansion of private healthcare facilities, rising awareness of infection control, and increased adoption of automated technologies.
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/automated-endoscope-reprocessors-aer-market-113732
Competitive Landscape
The market is highly competitive with global and regional players introducing innovative solutions, partnerships, and facility expansions. STERIS and Getinge maintain strong leadership positions through extensive product portfolios and international presence. Olympus Corporation is strengthening its reprocessing business with new sterilization facilities, while ASP (Fortive) and Steelco S.p.A. continue to expand their offerings. Regional players such as ARC Healthcare Solutions, CHOYANG, and NUOVA SB SYSTEM S.R.L. are leveraging technological improvements and strategic alliances to strengthen their positions.
Future Market Scope
The future of the AER market looks promising, with growth opportunities emerging across both developed and developing economies. Technological innovations integrating digital features such as process traceability, data logging, and remote monitoring will enhance compliance and operational efficiency. Compact and cost-effective AERs are expected to penetrate smaller healthcare centers, while large hospitals will continue to adopt advanced dual-basin and stationary systems for greater patient safety.
With increasing regulatory pressures, healthcare facilities worldwide are moving rapidly toward automation in endoscope reprocessing. By 2032, the AER market is expected to cross USD 1 billion, underscoring its crucial role in the global fight against healthcare-associated infections and its contribution to improving patient outcomes.
Conclusion
The Automated Endoscope Reprocessors (AER) market is positioned for consistent growth through 2032. Driven by rising healthcare standards, technological innovation, and regulatory enforcement, AERs are becoming indispensable in infection control protocols. While cost and training remain challenges, ongoing advancements and investments will ensure wider adoption across hospitals, clinics, and specialized facilities worldwide.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
